Thomas Bhatt

Thomas Bhatt focuses on the pharmaceutical stability and cold chain logistics of mRNA cancer vaccine products, a critical barrier to global access. His research has advanced lyophilization and lipid nanoparticle stabilization approaches that reduce the ultra-cold storage requirements of mRNA vaccines. He has characterized mRNA degradation kinetics under various storage conditions and developed predictive stability models. His work is enabling room-temperature or standard refrigerator-stable mRNA vaccine formulations that could transform personalized cancer vaccine delivery.